Pegfilgrastim 6 mg in 0.6 mL On-body Injection
RxNorm 2549331
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2549331 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pegfilgrastim 6 mg in 0.6 mL On-body Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.6 mL pegfilgrastim 10 mg/ML Injection
(Atom ID: 12639921)
SYPrescribable
Synonym (SY):
Pegfilgrastim 10 mg/ML per 0.6 mL On-body Injection
(Atom ID: 12874625)
PSNPrescribable
Prescribable Name (PSN):
Pegfilgrastim 6 mg in 0.6 mL On-body Injection
(Atom ID: 12874626)
SYPrescribable
Synonym (SY):
Pegfilgrastim 6 mg per 0.6 mL On-body Injection
(Atom ID: 12874624)
Patient Education
Pegfilgrastim Injection
Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Pegfilgrastim injection (Neulasta) is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. Pegfilgrastim is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.
[Learn More]
* Please review the disclaimer below.